Abstract |
|
Authors | Janna Paulsson, Maja Bradic Lindh, Malin Jarvius, Marjut Puputti, Monica Nistér, Nina N Nupponen, Werner Paulus, Ola Söderberg, Gregor Dresemann, Andreas von Deimling, Heikki Joensuu, Arne Ostman, Martin Hasselblatt |
Journal | International journal of cancer
(Int J Cancer)
Vol. 128
Issue 8
Pg. 1981-8
(Apr 15 2011)
ISSN: 1097-0215 [Electronic] United States |
PMID | 20589679
(Publication Type: Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 UICC. |
Chemical References |
- Benzamides
- Piperazines
- Pyrimidines
- Imatinib Mesylate
- Receptor, Platelet-Derived Growth Factor alpha
- Hydroxyurea
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Benzamides
- Brain Neoplasms
(drug therapy, metabolism, pathology)
- Drug Resistance, Neoplasm
- Female
- Glioblastoma
(drug therapy, metabolism, pathology)
- Humans
- Hydroxyurea
(administration & dosage)
- Imatinib Mesylate
- Immunoenzyme Techniques
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(drug therapy, metabolism, pathology)
- Phosphorylation
- Piperazines
(administration & dosage)
- Prognosis
- Pyrimidines
(administration & dosage)
- Receptor, Platelet-Derived Growth Factor alpha
(metabolism)
- Survival Rate
|